Novo Nordisk discovers and develops innovative medicines and makes them accessible to patients throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care, as well as in other therapeutic areas where the company can make a difference.
Access each of our location pages below to read more about our sites within the U.S. and learn more about our company’s History.
Clayton & Durham, NC
With a manufacturing presence in Clayton, North Carolina for more than 25 years, we are further expanding our production network by opening two additional manufacturing facilities in the Tar Heel state, including a $2 billion API facility in Clayton and a new tableting and packaging facility in Durham, NC.